Biomarkers and Therapeutic Targets of Oral Squamous Cell Carcinoma

Dear Colleagues,

Oral squamous cell carcinoma (OSCC) is one of the most malignant tumors across the world. Overall, the survival rate of OSCC patients is poor. Novel biomarkers or targets may provide new insights and options for the prediction and treatment of OSCC.

This Special Issue is entitled "Biomarkers and Therapeutic Targets of Oral Squamous Cell Carcinoma” and aims to present research on predictive markers, prognositic markers and therapeutic targets with their related mechanisms.

In recent years, immunotherapy has revolutionized cancer treatment, including OSCC treatment. However, the limited response of immunotherapy remains a significant problem, which we must face. Thus, biomarkers and targets related to the immunology of OSCC may be a promising option.

Authors are welcome to share original ariticles and review papers that present the latest research results and progress.

Dr. Weiwei Deng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• OSCC
• biomarker
• therapeutic target
• immunotherapy